MCID: VRL011
MIFTS: 72

Viral Infectious Disease

Categories: Infectious diseases, Respiratory diseases

Aliases & Classifications for Viral Infectious Disease

Summaries for Viral Infectious Disease

MedlinePlus : 43 Viruses are very tiny germs. They are made of genetic material inside of a protein coating. Viruses cause familiar infectious diseases such as the common cold, flu and warts. They also cause severe illnesses such as HIV/AIDS, smallpox, and Ebola. Viruses are like hijackers. They invade living, normal cells and use those cells to multiply and produce other viruses like themselves. This can kill, damage, or change the cells and make you sick. Different viruses attack certain cells in your body such as your liver, respiratory system, or blood. When you get a virus, you may not always get sick from it. Your immune system may be able to fight it off. For most viral infections, treatments can only help with symptoms while you wait for your immune system to fight off the virus. Antibiotics do not work for viral infections. There are antiviral medicines to treat some viral infections. Vaccines can help prevent you from getting many viral diseases.

MalaCards based summary : Viral Infectious Disease, also known as virus infection, is related to chronic active epstein-barr virus infection and viral meningitis, and has symptoms including fever, pruritus and pathological conditions, signs and symptoms. An important gene associated with Viral Infectious Disease is TLR9 (Toll Like Receptor 9), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Entecavir and Hops have been mentioned in the context of this disorder. Affiliated tissues include liver, t cells and testes, and related phenotypes are hematopoietic system and cellular

Disease Ontology : 12 A disease by infectious agent that results in infection, has material basis in Viruses.

CDC : 3 Powassan

Wikipedia : 76 A viral disease (or viral infection) occurs when an organism''s body is invaded by pathogenic viruses,... more...

Related Diseases for Viral Infectious Disease

Diseases related to Viral Infectious Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1398)
# Related Disease Score Top Affiliating Genes
1 chronic active epstein-barr virus infection 34.2 IFNG IL10 IL2
2 viral meningitis 32.5 CCL5 CXCL10 IFNG
3 intermediate uveitis 32.5 IFNG IL10 IL2 TNF
4 hepatitis a 32.4 IFNG IL10 MAVS TNF
5 hemorrhagic fever 32.3 IFNG IL10 TNF
6 tonsillitis 32.2 IFNG IL2 TLR9 TNF
7 meningitis 32.2 IFNG IL10 TLR9 TNF
8 bronchiolitis 32.2 CCL5 IFNG IL10 TLR9 TNF
9 tick-borne encephalitis 32.2 CCR5 CXCL10 IL10 TLR3
10 encephalitis 32.2 CCL5 CCR5 CXCL10 DDX58 IRF3 ITIH4
11 west nile virus 32.1 CCR5 DDX58 IFIH1 IFNA1 IRF3 TLR3
12 marburg hemorrhagic fever 32.1 IFNB1 TNF
13 hepatitis c 32.1 CXCL10 DDX58 IFNA1 IFNA2 IFNB1 IFNG
14 rubella 32.1 DDX58 IL10 TNF
15 la crosse encephalitis 32.0 DDX58 IFNB1 IRF3
16 murray valley encephalitis 32.0 IFNA1 IFNB1 IL2
17 hand, foot and mouth disease 32.0 IFNG IL10 TLR3
18 poliomyelitis 32.0 IFNG IL10 TNF
19 herpangina 32.0 IFNA1 IFNA2 IFNB1 TLR7
20 herpes zoster 32.0 IFNA2 IFNG IL10 IL2
21 yellow fever 32.0 CCL5 CCR5 IFNB1 IRF7 TLR9
22 chikungunya 32.0 CCL5 DDX58 MAVS TNF
23 hepatitis e 31.9 IFNG TLR3 TNF
24 newcastle disease 31.9 DDX58 IFNA1 IFNB1 IRF3 TNF
25 tropical spastic paraparesis 31.9 CCL5 IFNG IL10 IL2
26 viral hepatitis 31.9 IFNA1 IFNA2 MX1 TLR9 TNF
27 rabies 31.9 CCL5 CXCL10 IRF3 MX1 TLR3
28 vaccinia 31.9 IFNA1 IFNB1 IL2 IRF3 IRF7
29 staphylococcal toxic shock syndrome 31.9 IFNG TNF
30 japanese encephalitis 31.9 CCL5 CXCL10 DDX58 IFNB1 TLR3 TNF
31 herpes simplex 31.9 DDX58 IFIH1 IFNA1 IFNB1 IRF3 TLR3
32 omenn syndrome 31.8 IFNG IL10 TNF
33 measles 31.8 DDX58 IFIH1 IFNA1 IFNB1 IFNG IL2
34 common cold 31.8 CCL5 IFNA2 TLR9
35 severe acute respiratory syndrome 31.8 CCL5 CXCL10 IFNA1 IFNB1 IFNG IRF3
36 hepatitis b 31.7 IFNA1 IFNA2 IFNG TNF
37 aphthous stomatitis 31.7 IL10 IL2 TNF
38 human immunodeficiency virus infectious disease 31.7 CCL5 CCR5 IFNA1 IFNG IL10 IL2
39 smallpox 31.7 IFNG IL2 TNF
40 viral encephalitis 31.7 CCL5 CXCL10 IL10 MX1 TNF
41 mumps 31.6 IFNG IL2 TNF
42 influenza 31.5 CCL5 CXCL10 DDX58 IFIH1 IFNA1 IFNB1
43 genital herpes 31.1 CCL5 IL10 TLR9
44 lichen planus 30.8 IFNG MX1 TLR9 TNF
45 eczema herpeticum 30.7 IFNG IRF3 IRF7
46 pneumonia 30.6 CCL5 IL10 TLR9 TNF
47 lymphadenitis 30.6 IFNG IL10 TNF
48 myeloma, multiple 30.6 IFNA1 IL2 TLR9 TNF
49 hepatitis c virus 30.5 CCR5 DDX58 IFIH1 IFNG IRF3 IRF7
50 neuritis 30.5 CCL5 CXCL10 IFNG TNF

Graphical network of the top 20 diseases related to Viral Infectious Disease:



Diseases related to Viral Infectious Disease

Symptoms & Phenotypes for Viral Infectious Disease

UMLS symptoms related to Viral Infectious Disease:


fever, pruritus, pathological conditions, signs and symptoms

MGI Mouse Phenotypes related to Viral Infectious Disease:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.24 CCL5 CCR5 CXCL10 DDX58 IFIH1 IFNB1
2 cellular MP:0005384 10.21 CCR5 CXCL10 DDX58 IFIH1 IFNG IL10
3 homeostasis/metabolism MP:0005376 10.2 CCR5 CXCL10 DDX58 IFIH1 IFNB1 IFNG
4 immune system MP:0005387 10.16 CCL5 CCR5 CXCL10 DDX58 IFIH1 IFNB1
5 digestive/alimentary MP:0005381 10.01 CCR5 DDX58 IFNG IL10 IL2 MAVS
6 mortality/aging MP:0010768 9.77 CCR5 CXCL10 DDX58 IFIH1 IFNG IL10
7 liver/biliary system MP:0005370 9.76 CCR5 DDX58 IFIH1 IFNG IL10 IL2
8 neoplasm MP:0002006 9.28 CCR5 DDX58 IFNB1 IFNG IL10 IL2

Drugs & Therapeutics for Viral Infectious Disease

Drugs for Viral Infectious Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1229)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Entecavir Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 142217-69-4 153941
2 Hops Approved Phase 4,Not Applicable
3
Lamivudine Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 134678-17-4 60825
4
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable,Early Phase 1 104987-11-3 445643 439492
5
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 22916-47-8 4189
6
Telbivudine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 3424-98-4 159269
7
Ethiodized oil Approved, Investigational Phase 4,Phase 2,Not Applicable 8008-53-5
8
Isoniazid Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 54-85-3 3767
9
Pentoxifylline Approved, Investigational Phase 4,Phase 3,Phase 1 6493-05-6 4740
10
Ribavirin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 36791-04-5 37542
11
Amantadine Approved Phase 4,Phase 3,Phase 1,Phase 2 768-94-5 2130
12
Dopamine Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 51-61-6, 62-31-7 681
13
Peginterferon alfa-2a Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 198153-51-4 5360545
14
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 159351-69-6 6442177
15
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 53123-88-9 46835353 6436030 5284616
16
Ezetimibe Approved Phase 4,Phase 2,Phase 1 163222-33-1 150311
17
Ciprofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 85721-33-1 2764
18
rituximab Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 174722-31-7 10201696
19
Peginterferon alfa-2b Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 99210-65-8, 215647-85-1
20
Mycophenolic acid Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 24280-93-1 446541
21
Oseltamivir Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 204255-11-8, 196618-13-0 65028
22
Tocopherol Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 1406-66-2 14986
23
Ritonavir Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 155213-67-5 392622
24
Ledipasvir Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 1256388-51-8 67505836
25
Sofosbuvir Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 1190307-88-0 45375808
26
Aluminum hydroxide Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 21645-51-2
27
Neomycin Approved, Vet_approved Phase 4,Phase 2,Phase 1,Not Applicable 1404-04-2 8378
28 tannic acid Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
29
Benzocaine Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 94-09-7, 1994-09-7 2337
30
Nitazoxanide Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 55981-09-4 41684
31
Lopinavir Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 192725-17-0 92727
32
Efavirenz Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 154598-52-4 64139
33
Adefovir Dipivoxil Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 142340-99-6 60871
34
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83-43-2 6741
35
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-24-8 5755
36
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 53-03-2 5865
37
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 302-25-0
38
Methylprednisolone hemisuccinate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 2921-57-5
39
Pioglitazone Approved, Investigational Phase 4,Phase 2,Not Applicable 111025-46-8 4829
40
Acarbose Approved, Investigational Phase 4 56180-94-0 441184
41
Metformin Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 657-24-9 14219 4091
42
Montelukast Approved Phase 4,Phase 3,Phase 2,Not Applicable 158966-92-8 5281040
43
Ethanol Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 64-17-5 702
44
Emtricitabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 143491-57-0 60877
45
Abacavir Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 136470-78-5 65140 441300
46 Dolutegravir Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1051375-16-6 54726191
47
Candesartan cilexetil Approved Phase 4 145040-37-5 2540
48
Angiotensin II Approved, Investigational Phase 4,Phase 1,Phase 2 11128-99-7, 68521-88-0, 4474-91-3 172198 65143
49
Lercanidipine Approved, Investigational Phase 4 100427-26-7 65866
50
leucovorin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 58-05-9 6006 143

Interventional clinical trials:

(show top 50) (show all 10000)
# Name Status NCT ID Phase Drugs
1 Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma Unknown status NCT01765231 Phase 4 Entecavir prophylaxis;Observation arm
2 Pilot Study to Describe Immune Responses of Healthy Women Following Immunization With Varicella Zoster Virus Vaccine Unknown status NCT02514018 Phase 4
3 Study of Immune Responses After Vaccination Against Seasonal Influenza Virus and Against Influenza H1N1-v Pandemic Virus in a Medical Staff. Unknown status NCT01063608 Phase 4
4 Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma Unknown status NCT00768157 Phase 4 antiviral treatment (lamivudine or entecavir)
5 Hepatitis C in Renal Transplant Recipients Unknown status NCT02108301 Phase 4 tacrolimus-cyclosporine A
6 Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy Unknown status NCT01102335 Phase 4 Telbivudine
7 The Impact of Vitamin on the Clinical Course in Cases Infected by Novel H1N1 Influenza Virus A Unknown status NCT01127282 Phase 4 Vitamin (vitamin A 15 mg,C 500 mg, E 400IU);Placebo (digestive tablet)
8 Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL) Unknown status NCT01875952 Phase 4 Isoniazid
9 Efficacy of PTX+IFN Alpha+ RBV on Hepatitis C Virus Coinfected HIV Patients Unknown status NCT02008214 Phase 4 Pentoxifylline;Placebo
10 Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients Unknown status NCT02624349 Phase 4 Quadravalent human papillomavirus vaccine
11 Topical Cyclosporine for the Treatment of Dry Eye in Patients Infected With the Human Immunodeficiency Virus Unknown status NCT00797030 Phase 4 cyclosporine and sodium carboximethycellulose;sodium carboximethycellulose
12 Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA) Unknown status NCT00127777 Phase 4 Amantadine sulphate (in addition to standard treatment)
13 Studying the Effect of Changing Immunosuppression in Case of Polyoma BK Virus Infection of the Renal Transplant Unknown status NCT01289301 Phase 4 mTOR inhibitor (everolimus);cyclosporine or tacrolimus
14 Entecavir for Chronic Hepatitis B Patients With Persistently Normal ALT Unknown status NCT01833611 Phase 4 Entecavir;placebo
15 Thymalfasin Adjuvant Therapy in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) After Curative Resection Unknown status NCT02281266 Phase 4 thymalfasin;nucleoside analog (suggest to use entecavir)
16 Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection Unknown status NCT01594905 Phase 4 Entecavir + Tenofovir (MDR group)
17 Hepatitis B Virus (HBV) Antibody (Anti-HBs) Booster Program for the Production of Hepatitis B Immune Globulin (HBIG) Unknown status NCT01311674 Phase 4
18 Study of Ezetimibe for Chronic Hepatitis C Virus (HCV) Infection in Liver Transplant Candidates (EZE-2) Unknown status NCT02768545 Phase 4 Ezetimibe
19 Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Unknown status NCT01954810 Phase 4
20 Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females Unknown status NCT01031069 Phase 4
21 Ciprofloxacin for Prevention of BK Infection Unknown status NCT01789203 Phase 4 Ciprofloxacin;placebo
22 Entecavir for Patients With Decompensated Hepatitis B Virus (HBV)-Related Cirrhosis Unknown status NCT00663182 Phase 4 Entecavir
23 Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy Unknown status NCT01768195 Phase 4 Entecavir prophylaxis
24 Comparison of the Cellular and the Humoral Immunogenicity, Safety of Different Trivalent Influenza Vaccines Unknown status NCT01119157 Phase 4
25 A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD) Unknown status NCT01731301 Phase 4 Ribavirin;Peginterferon;Boceprevir
26 Entecavir for Biological Agents Associated HBV Reactivation in Inflammatory Arthritis Patients Unknown status NCT01907230 Phase 4 Entecavir
27 Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls? Unknown status NCT01101750 Phase 4
28 The Effect and Safety of the Seasonal Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Not on Dialysis Unknown status NCT02105519 Phase 4
29 TO Compare the Triple Drug Therapy and Dual Therapy . Unknown status NCT02075242 Phase 4 Mycophenolate Mofetil;Tacrolimus
30 Hansenula-derived Pegylated Interferon in Treatment of Patients With Chronic Hepatitis C Unknown status NCT01649245 Phase 4 Reiferon retard
31 Improved Prevention of Perinatal Hepatitis B Transmission Unknown status NCT01133184 Phase 4
32 Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients Unknown status NCT00526448 Phase 4 ribavirin;ribavirin;Peginterferon alfa-2a;epoetin beta
33 Banlangen Granules Anti-seasonal Influenza Study Unknown status NCT02232945 Phase 4 placebo of oseltamivir phosphate;oseltamivir phosphate;Banlangen (Radix Isatidis) granules;placebo of Banlangen(Radix Isatidis) granules
34 Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B Patients Unknown status NCT01148576 Phase 4 entecavir;entecavir;essentiale + entecavir;Vitamin E + entecavir
35 Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study Unknown status NCT00936013 Phase 4 oseltamivir;oseltamivir and chinese medicinal herbs
36 Atazanavir/r + Lamivudine Dual Therapy Unknown status NCT01599364 Phase 4 Atazanavir, ritonavir, lamivudine
37 Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease Patients Unknown status NCT00823550 Phase 4 Entecavir;Lamivudine
38 High Intensity Focused Ultrasound Ablation Virus Myomectomy to Treat Uterine Fibroids Unknown status NCT01239641 Phase 4
39 Therapy With Ledipasvir/Sofosbuvir in Patients With Genotype 1 HCV Infection Receiving Opiate Substitution Therapy Unknown status NCT02638233 Phase 4 Sofosbuvir 400mg / Ledipasvir 90 mg (FDC)
40 Efficacy and Safety Study of Telbivudine to Prevent Perinatal Transmission Unknown status NCT00939068 Phase 4 Telbivudine
41 Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With Baraclude Unknown status NCT02523547 Phase 4 Cavir;Baraclude
42 7-valent Pneumococcal Conjugated Vaccination Unknown status NCT00885625 Phase 4
43 Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-responders Unknown status NCT01451801 Phase 4
44 Optimizing Treatment Programs for Chronic Kidney Disease-mineral and Bone Disorder and Malnutrition Unknown status NCT02005302 Phase 4 1,25(OH)2 Vitamin D3;Vitamin D2
45 Twinrix Alternative Schedule Study Unknown status NCT00216229 Phase 4
46 Trial Comparing the Efficacy, Tolerability and Safety Between Three Arms in Treatment of HCV in Egyptian Population Unknown status NCT01896609 Phase 4 Bon one in Arm 3;Xerovirinc in Arm 2;Ribavirin in Arm 1
47 Adjusting Antiretroviral Therapy Dosage Using Therapeutic Drug Monitoring Unknown status NCT00836212 Phase 4 Reducing dose of Lopinavir;Reducing dose of efavirenz
48 Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV Vaccine Unknown status NCT01841671 Phase 4
49 Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy Unknown status NCT01341743 Phase 4 Entecavir;Entecavir, Adefovir;Entecavir, Adefovir
50 Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous Treatment Unknown status NCT01724723 Phase 4 entecavir (BARACLUDE®)

Search NIH Clinical Center for Viral Infectious Disease

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: arbovirus infections

Genetic Tests for Viral Infectious Disease

Anatomical Context for Viral Infectious Disease

MalaCards organs/tissues related to Viral Infectious Disease:

41
Liver, T Cells, Testes, Kidney, B Cells, Brain, Lung

Publications for Viral Infectious Disease

Articles related to Viral Infectious Disease:

(show top 50) (show all 8540)
# Title Authors Year
1
Increased risk of anal squamous cell carcinoma in HIV-positive men with prior hepatitis B virus infection. ( 30325778 )
2019
2
Administration of plasmacytoid dendritic cell-stimulative lactic acid bacteria is effective against dengue virus infection in mice. ( 30365042 )
2019
3
Bilateral pulmonary nodules and intravascular pulmonary histiocytosis: A rare presentation of hemophagocytic lymphohistiocytosis secondary to Epstein-Barr Virus infection. ( 30456165 )
2019
4
TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection. ( 30421643 )
2019
5
Hyperbranched rolling circle amplification (HRCA)-based fluorescence biosensor for ultrasensitive and specific detection of single-nucleotide polymorphism genotyping associated with the therapy of chronic hepatitis B virus infection. ( 30262063 )
2019
6
Aberrant DNA methylation profile of hepatitis B virus infection. ( 30118556 )
2019
7
Skeletal muscle mass depletion in patients with hepatitis C virus infection. ( 30179904 )
2019
8
Corrigendum to "Antibody-based immunotherapy of acyclovir resistant ocular herpes simplex virus infection" [Virology 512 (2017) 194-200]. ( 30290967 )
2019
9
Guava flavonoid glycosides prevent influenza A virus infection via rescue of P53 activity. ( 30153335 )
2019
10
Zika virus infection activates sting-dependent antiviral autophagy in the Drosophila brain. ( 30260713 )
2019
11
Cutaneous features of Zika virus infection: a clinicopathological overview. ( 30267436 )
2019
12
Epileptic spasms as the presenting seizure type in a patient with a new "O" of TORCH, congenital Zika virus infection. ( 30456170 )
2019
13
Diagnosis of Human Immunodeficiency Virus Infection. ( 30487166 )
2019
14
Intrapartum Management of Women With Human Immunodeficiency Virus Infection. ( 30531590 )
2019
15
Predictors of chronic fatigue in adolescents six months after acute Epstein-Barr virus infection: A prospective cohort study. ( 30261303 )
2019
16
Characterization of maize translational responses to sugarcane mosaic virus infection. ( 30355529 )
2019
17
The 1b gene of raspberry bushy dwarf virus is a virulence component that facilitates systemic virus infection in plants. ( 30447555 )
2019
18
Ebola Virus Infection Associated with Transmission from Survivors. ( 30500321 )
2019
19
Severe Respiratory Syncytial Virus Infection in Hospitalized Children Less Than 3 Years of Age in a Temperate and Tropical Climate. ( 30531526 )
2019
20
Cloning and expression of the lectin gene from the mushroom Agrocybe aegerita and the activities of recombinant lectin in the resistance of shrimp white spot syndrome virus infection. ( 30031870 )
2019
21
Dynamics of Lymphocyte Reconstitution After Hematopoietic Transplantation During Chronic Lymphocytic Choriomeningitis Virus Infection. ( 29620933 )
2018
22
Outbreak of Hepatitis A Virus Infection Among Adult Patients of a Mental Hospital-Los Angeles County, 2017 - CORRECTION. ( 29970205 )
2018
23
Zika Virus Infection, Pregnancy and Microcephaly. ( 29341036 )
2018
24
The molecular tweezer CLR01 inhibits Ebola and Zika virus infection. ( 29428508 )
2018
25
<i>In vitro</i> measles virus infection of human lymphocyte subsets demonstrates high susceptibility and permissiveness of both naive and memory B-cells. ( 29437964 )
2018
26
Hepatitis C virus infection in children in the era of direct-acting antiviral. ( 29962813 )
2018
27
Designing B- and T-cell multi-epitope based subunit vaccine using immunoinformatics approach to control Zika virus infection. ( 29900580 )
2018
28
Prevalence of human immunodeficiency virus infection in brain glioma patients: Is the virus protective from gliomas? ( 29930869 )
2018
29
Epidemiology and risk factors for hepatitis C virus infection in a high-prevalence population. ( 29429421 )
2018
30
Inflammation-Induced, STING-Dependent Autophagy Restricts Zika Virus Infection in the Drosophila Brain. ( 29934091 )
2018
31
Enhanced identification of maternal hepatitis C virus infection using existing public health surveillance systems. ( 29972246 )
2018
32
The PA-interacting host protein nucleolin acts as an antiviral factor during highly pathogenic H5N1 avian influenza virus infection. ( 29974255 )
2018
33
Synergic effect of curcumin and its structural analogue (Monoacetylcurcumin) on anti-influenza virus infection. ( 29976394 )
2018
34
Defining the elusive boundaries of chronic active Epstein-Barr virus infection. ( 29866887 )
2018
35
Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection. ( 29593047 )
2018
36
Extreme heterogeneity of influenza virus infection in single cells. ( 29451492 )
2018
37
Acute respiratory distress syndrome in a man with Epstein-Barr virus infection-induced hypocomplementemic urticarial vasculitis. ( 29458992 )
2018
38
In Reply-Cardiac Compromise in Zika Virus Infection. ( 29395352 )
2018
39
Electrocardiographic Finding in Zika Virus Infection. ( 29907402 )
2018
40
Zika virus infection in Nicaraguan households. ( 29851968 )
2018
41
Diagnosis and outcomes of pregnant women with Zika virus infection in two municipalities of Risaralda, Colombia: Second report of the ZIKERNCOL study. ( 29894797 )
2018
42
Incidence of new hepatitis C virus infection is still increasing in French MSM living with HIV. ( 29438195 )
2018
43
Hepatitis B virus infection and the risk of cancer in the elderly US population. ( 29974477 )
2018
44
Hepatitis C virus infection and risk of osteoporotic fracture: A systematic review and meta-analysis. ( 29322660 )
2018
45
Congenital syndrome associated with Zika virus infection among live births in Brazil: a description of the distribution of reported and confirmed cases in 2015-2016. ( 29972474 )
2018
46
Asymptomatic Prenatal Zika Virus Infection and Congenital Zika Syndrome. ( 29732381 )
2018
47
Bilateral central retinal artery occlusion as presenting manifestation of human immunodeficiency virus infection. ( 29480272 )
2018
48
Safety and Efficacy of Sofosbuvir and Daclatasvir for Hepatitis C Virus Infection in Patients with I^-Thalassemia Major. ( 29743790 )
2018
49
Autoimmune neuroretinopathy and Zika virus infection. ( 29909123 )
2018
50
Development and Validation of a Serologic Test Panel for Detection of Powassan Virus Infection in U.S. Patients Residing in Regions Where Lyme Disease Is Endemic. ( 29359181 )
2018

Variations for Viral Infectious Disease

Expression for Viral Infectious Disease

Search GEO for disease gene expression data for Viral Infectious Disease.

Pathways for Viral Infectious Disease

Pathways related to Viral Infectious Disease according to GeneCards Suite gene sharing:

(show top 50) (show all 68)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.98 CCL5 CCR5 CXCL10 DDX58 IFIH1 IFNA1
2
Show member pathways
13.72 CCL5 CCR5 CXCL10 IFNA1 IFNA2 IFNB1
3
Show member pathways
13.57 CCL5 IFNA1 IFNA2 IFNB1 IFNG IL10
4
Show member pathways
13.46 CCL5 CCR5 CXCL10 IL10 IL2 TLR3
5
Show member pathways
13.41 CCL5 CCR5 CXCL10 DDX58 IFNA1 IFNA2
6
Show member pathways
13.35 IFNA1 IFNA2 IFNB1 IL2 IRF3 IRF7
7
Show member pathways
13.17 CCL5 CCR5 DDX58 IFIH1 IFNA1 IFNA2
8
Show member pathways
13.07 IFNA1 IFNA2 IFNB1 IL2 IRF3 MX1
9
Show member pathways
12.92 IFNA1 IFNA2 IFNG IL10 IL2 TNF
10
Show member pathways
12.87 CCL5 CXCL10 DDX58 IFIH1 IFNA1 IFNA2
11
Show member pathways
12.73 IL2 TLR3 TLR7 TLR9 TNF
12
Show member pathways
12.68 IRF3 IRF7 TLR3 TLR7 TLR9 TNF
13
Show member pathways
12.68 CCL5 CXCL10 IFNA1 IFNA2 IFNB1 IFNG
14
Show member pathways
12.66 DDX58 IFNA1 IFNA2 IFNB1 IFNG IRF3
15
Show member pathways
12.6 IFNA1 IFNA2 IFNB1 IFNG IL2 TNF
16 12.55 CCL5 CXCL10 DDX58 IFIH1 IFNA1 IFNG
17
Show member pathways
12.53 DDX58 IFIH1 IRF3 IRF7 MAVS TLR3
18
Show member pathways
12.51 CCR5 IFNA1 IFNA2 IFNB1 IFNG IL10
19
Show member pathways
12.48 CCR5 IFNG IL10 IL2 TNF
20
Show member pathways
12.46 IRF3 IRF7 TLR3 TLR7 TLR9
21
Show member pathways